DXCM · Healthcare

DEXCOM INC

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window

News · 2026-08-08

Competition and Market ShareImportance 51 · Surprise 64
Senseonics reported approximately 120% year-over-year revenue growth to $14.5 million in the second quarter, driven primarily by U.S. expansion and increased adoption of its Eversense continuous glucose monitoring…

Competition and Market ShareImportance 51 · Surprise 64
Senseonics reported approximately 120% year-over-year revenue growth to $14.5 million in the second quarter, driven primarily by U.S. expansion and increased adoption of its Eversense continuous glucose monitoring…

Competition and Market ShareImportance 51 · Surprise 64
Senseonics reported approximately 120% year-over-year revenue growth to $14.5 million in the second quarter, driven primarily by U.S. expansion and increased adoption of its Eversense continuous glucose monitoring…

Competition and Market ShareImportance 51 · Surprise 64
Senseonics reported approximately 120% year-over-year revenue growth to $14.5 million in the second quarter, driven primarily by U.S. expansion and increased adoption of its Eversense continuous glucose monitoring…
Revenue Performance and MixImportance 47 · Surprise 22
DexCom reported quarterly revenue of $1.31 billion, up 13.1% year over year. Quarterly EPS was $0.70, exceeding consensus estimates. The available reporting does not provide segment, geographic, or sequential revenue…
Litigation and Legal RiskImportance 31 · Surprise 42
Levi & Korsinsky filed a U.S. securities class action against DexCom on behalf of investors who purchased the company’s securities from January 8, 2024, through September 17, 2025. The complaint alleges that…